Nose filler: why is it injected in small amounts rather than all at once?

Nose filler: why is it injected in small amounts rather than all at once?

Jangju Kim25 min readEditorial policy

Key takeaways

  • Why the nose is handled more cautiously than other filler sites
  • Where the one-pass approach and the divided approach actually diverge
  • How volume and injection depth get decided in a consultation
  • What the reported complication rates are, with figures

You turn your head to the side in the mirror and the bridge of your nose looks flatter than you remembered. In photos the tip seems to drop a little, or the line from between the brows down to the bridge reads as unremarkable. Surgery feels like a big step, so an injectable option is usually the first thing people look into.

Which leads to a request injectors hear constantly: do the whole height in one sitting. It's a reasonable thing to want. One appointment, one recovery, and a result you can see the same day.

The catch is anatomical rather than commercial. The nose has less space under the skin than anywhere else that gets filler, and its blood supply sits in the layer immediately above where the product belongs. This guide covers why small, divided amounts became the standard approach, what the reported complication figures actually look like, and how the layer and the volume get decided in a consultation.

This article summarizes treatment information from Beautystone Clinic in Hongdae, Seoul. Individual results vary, and whether a treatment suits you is a decision to make with a board-certified dermatologist.

The Nose Has the Least Room of Any Filler Site

The Nose Has the Least Room of Any Filler SiteThe Nose Has the Least Room of Any Filler Site

The bridge and the tip sit over cartilage and bone with very little space in between. A 2023 review in an otolaryngology journal notes that the safest location to place filler in the nose is the deep areolar plane just superficial to the periosteum or perichondrium, deep to the muscle layer and the nasal arteries. The same review states that the injection should be placed in the midline, that the injector must stay mindful a vessel may be present there anyway, and that aspiration before injection should therefore be performed in every case.

The muscle layer it refers to is the SMAS*, which sits relatively superficially. The vascular network of the nose runs between that layer and the skin, so product placed too shallow ends up gathering next to vessels rather than away from them.

SMAS: a thin sheet of fascia under the skin that connects with the muscles of facial expression. In the nose, the blood vessels run between this sheet and the skin.

The same review is blunt about how variable the anatomy is. In 14 percent of cadaver specimens the dorsal nasal artery crossed the midline to join the artery on the other side, which is why the authors write that vascular injury remains possible even in experienced hands and that any injector must be prepared to manage it.

The Nose Has the Least Room of Any Filler SiteThe Nose Has the Least Room of Any Filler Site

Small Increments Versus Filling It in One Pass

Small Increments Versus Filling It in One PassSmall Increments Versus Filling It in One Pass

The volumes described in the literature are smaller than most people expect. The review above says that for raising a low radix, filler is placed in small boluses of 0.05 ml or less to avoid blunting the nasofrontal angle. For a dorsal hump it describes boluses of under 0.05 ml, with the product molded into place and reassessed incrementally, and for sidewall concavities it gives increments of 0.05 to 0.1 ml.

Pressure gets the same attention. A 2020 paper on periocular and perinasal filler complications states that the product should be introduced at low flow to avoid overcoming mean arterial pressure, and that keeping the needle in constant motion during injection helps prevent product from depositing inside a vessel. The same paper notes that at the nasal dorsum the vascular network is located entirely in the subcutaneous plane, so injections are kept deep in the preperichondrial and preperiosteal planes, and that while the syringe is gently aspirated first, the absence of blood return does not rule out a punctured vessel.

Side by side, the two approaches diverge like this.

What you're comparingSmall divided amountsFilling in one pass
Volume per depositBoluses around 0.05 mlWhatever the target height takes
Injection pressureLow flow, deliberately slowPressure concentrates in a tight space
When you judge the shapeMolded and reassessed as you goOnly after swelling settles
Room to adjustAdd at the next session, or stopReducing it means dissolving it
Telling shape from swellingSmall volumes are easier to readHeight and swelling blur together

None of which makes the divided approach a safe-by-default choice. The same review says that injection into the nose is a high-risk procedure and not a technique for the novice injector, and that a thorough understanding of nasal anatomy, careful patient selection and conservative treatment using small amounts injected slowly in the correct plane are all necessary.

Why Beautystone Clinic Starts Small and Splits the Sessions

Why Beautystone Clinic Starts Small and Splits the SessionsWhy Beautystone Clinic Starts Small and Splits the Sessions

The first thing a nose consultation here settles isn't how much to inject. It's which part of the profile is actually reading as low, the radix, the mid dorsum or the tip, and then skin thickness, previous injectable history and whether there's been nasal surgery. The layer and the volume follow from that.

Splitting the sessions gets explained in the same conversation. The first session puts in less than the target, and once the swelling settles the comparison shows which areas still need something and which are already fine. Fill to the target in one go and that reference point is gone.

The record gets made at the visit too. A profile photo taken at the same angle under the same light, plus a note of where each deposit went, means the next session is decided by comparison rather than by impression. Going over the early warning signs of a vascular complication and how to reach us if they appear is part of that first appointment as well.

Why Beautystone Clinic Starts Small and Splits the SessionsWhy Beautystone Clinic Starts Small and Splits the Sessions

How a Nose Filler Session Actually Runs

How a Nose Filler Session Actually RunsHow a Nose Filler Session Actually Runs

It starts with the profile. The low points and the high points next to them get separated out, and the question becomes which of them to fill so the line reads as continuous. A drooping tip isn't always solved by raising the bridge, so the plan names the areas that stay untouched as well as the ones that get product.

The injection itself goes into the deep plane along the midline in small deposits. The shape gets molded and checked between deposits, and if the line already reads well the session stops there even with volume left in the syringe. The review above describes exactly that: molded into place and reassessed incrementally.

Duration is hard to put a single number on. A dermatology reference says that for hyaluronic acid filler the augmentation usually lasts anywhere between 3 and 9 months, and most people have 2 to 3 treatments per year. The nasal review reports something different: duration of effect for hyaluronic acid products ranging from 6 months to 18 years depending on product and site, with multiple authors reporting duration of up to 8 years in the nose after a single injection. The two aren't in conflict so much as measuring different sites and products, which is why the honest answer for a nose is to review the result after the first session and plan from there.

The complication figures are on record as well. A systematic review and meta-analysis of 37 publications and 8,604 patients undergoing non-surgical rhinoplasty, cited in the same review, found an overall complication rate of 2.52 percent, with bruising at 1.58 percent as the most common. Major complications were reported as transient vessel occlusion at 0.35 percent, vision loss at 0.09 percent and skin necrosis at 0.08 percent. A separate literature review found that among cases of filler-related visual change, the nasal region was the most common injection site at 56.3 percent, followed by the glabella at 27.1 percent, the forehead at 18.8 percent and the nasolabial fold at 14.6 percent. Rare in absolute terms, in other words, and still the site that comes up first.

What to Sort Out Before the Visit

What to Sort Out Before the VisitWhat to Sort Out Before the Visit

Bring profile photos. A three-quarter view and a straight side view show where the line breaks far better than a front-on shot does. If you have a reference photo of a look you like, bring that too, though it works as a direction rather than a target, since a different underlying bone structure won't produce the same line.

Then your injectable history. Whether anything has been placed in your nose before, whether that was filler or thread, whether you've had nasal surgery, and whether a previous product might still be in there. A surgically altered nose can have altered vascular anatomy, which changes how the layer is chosen.

Last, the calendar. Swelling in the nose takes a few days to settle, and dividing the work across sessions adds that much more time. If something is coming up, it's worth counting backwards to pick the first session. After an injection, pain on one side that's clearly out of proportion, skin that turns pale or white, or any blurring of vision are reasons to get in touch immediately rather than waiting for the next appointment.

Ask a question

References

  1. the safest location to place filler in the nose is the deep areolar plane just superficial to the periosteum or perichondrium, deep to the muscle layer and the nasal arteries — PubMed Central
  2. the product should be introduced at low flow to avoid overcoming mean arterial pressure, and that keeping the needle in constant motion during injection helps prevent product from depositing inside a vessel — PubMed Central
  3. the augmentation usually lasts anywhere between 3 and 9 months, and most people have 2 to 3 treatments per year — DermNet NZ

Frequently asked questions

Q. Can I ask for the full height in one nose filler session?

A. You can ask, but it isn't advisable. The volumes in the literature are 0.05 ml or less at the radix and 0.05 to 0.1 ml at the sidewall. Putting a lot into a tight space concentrates pressure, and height becomes hard to judge while swelling is present. Starting small leaves room to add later.

Q. Does aspirating the syringe make a bridge injection safe?

A. It's done, but it doesn't settle the question. The 2020 paper says the syringe is gently aspirated to check for blood return, while noting that the absence of return does not rule out a punctured vessel. That's why depth, midline placement, low flow and keeping the needle moving are all used together.

Q. Does nose filler last longer than filler in other areas?

A. Longer durations have been reported there. A dermatology reference puts hyaluronic acid filler at 3 to 9 months in general, while the nasal review cites multiple authors reporting up to 8 years in the nose after a single injection. The range is wide by product and site, so the result of your first session is the better guide.

Q. How often are nose filler complications actually reported?

A. In a meta-analysis of 8,604 patients the overall rate was 2.52 percent, with bruising at 1.58 percent the most common. Transient vessel occlusion came in at 0.35 percent, vision loss at 0.09 percent and skin necrosis at 0.08 percent. Rare, though among visual-change cases the nose was the leading site at 56.3 percent.

Jangju Kim

Jangju Kim Senior Director

JANGJU KIM

Dr. Jangju Kim is a clinic director at STON Clinic, LOTTE HOTEL in Myeongdong.

Career / Education

  • 현) 스톤클리닉 명동 롯데호텔 원장
  • 경희대학교 의과대학 졸업
View profile

Comments